Insight Molecular Diagnostics Inc.
IMDX· Nasdaq
IMDXInsight Molecular Diagnostics Inc.
Filed Mar 11, 2022 · 10-K · 70 days after period end · 0001493152-22-006677
| Metric | Q4 2021 | Q4 2020 | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Revenue | $3.59M | $503.00K | — | — |
| Net Income | -$35.89M | -$6.31M | -$7.95M | -$4.50M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Insight Molecular Diagnostics Inc. · CIK 1642380 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 11, 2022 · 70 d after period end
